BioXcel completed a market assessment for at-home IGALMI use, finding strong prescriber and payer interest. The company submitted an sNDA for at-home use in acute agitation associated with bipolar disorders or schizophrenia.
A longitudinal study of 460,000 teenagers found adolescent cannabis use was linked to higher risks of later bipolar, psychotic, anxiety and depression diagnoses. Separate research and expert guidance say THC effects, especially long term, still need more study.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07794696 |
Family Videos and Virtual Reality in Intensive Care Patients |
COMPLETED | NA |
| NCT06808984 |
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease |
RECRUITING | PHASE2 |
